Symbol
CNTX on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock, par value $0.001 per share
Latest Disclosed Ownership
14.7M shares
Security Ownership
16.4%
Shares, Excluding Options vs Price
Value, Excluding Options

MPM BioImpact LLC ownership in Context Therapeutics Inc. Common Stock, par value $0.001 per share (CNTX)

2025-01-08 - MPM BioImpact LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 14.7M shares of Context Therapeutics Inc. Common Stock, par value $0.001 per share (CNTX). This represents 16.4% percent ownership of the company.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.